Tolfer

Tolfer, specifically known as Tolfedine (containing Tolfenamic Acid), is a well-established pharmaceutical product in the veterinary and human medicine sectors. It was originally developed for its potent anti-inflammatory and analgesic properties. The brand has a strong presence in the European market, where it is utilized for managing pain and inflammation in both livestock and small animals.

The global footprint of Tolfer is managed through advanced pharmaceutical manufacturing facilities located primarily in Europe, ensuring high quality and regulatory compliance. Over the years, the brand has transitioned through various corporate structures to settle under the stewardship of major veterinary healthcare groups.

Currently, the brand is owned by the Vetoquinol Group, a leading global player in the animal health industry headquartered in France. Since its acquisition, Vetoquinol has integrated Tolfer into its expansive portfolio, distributing the product through its international network of subsidiaries and partner distributors to serve veterinarians worldwide.